ArticleNeuroprotection (Chichester, England)2023

Exploiting moderate hypoxia to benefit patients with brain disease: Molecular mechanisms and translational research in progress.

Hannelore Ehrenreich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.